Page last updated: 2024-11-07

n-myristoyl glycinal diethylacetal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID122090
CHEMBL ID1980599
SCHEMBL ID6727234
MeSH IDM0161050

Synonyms (16)

Synonym
nsc-623914
n-myristoyl glycinal diethylacetyl
NCI60_007157
n-myr-goa
nsc623914
tetradecanamide, n-(2,2-diethoxyethyl)-
n-myristoyl glycinal diethylacetal
n-(2,2-diethoxyethyl)tetradecanamide
115433-72-2
1u99r4wi7t ,
unii-1u99r4wi7t
nsc 623914
SCHEMBL6727234
CHEMBL1980599
DTXSID70151098
n-myristoylglycinal diethyl acetal
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]